Oxytocin is a neuropeptide involved in animal and human reproductive and social behavior, with implications for a range of psychiatric disorders.
Introduction
Oxytocin is an evolutionarily conserved neuropeptide implicated in an array of social and reproductive behaviors, and its role in complex behavioral traits and in the pathophysiology of mental health conditions has attracted considerable attention (1) . Oxytocin is mostly synthesized in neurons in the supraoptic nucleus and the paraventricular nucleus, and released both systemically and centrally. Human research has shown beneficial effects of intranasal oxytocin on performance on tests assessing social cognition (2) , gaze to the eye region (3) , and the retrieval of social cues (4). Moreover, single nucleotide polymorphisms in oxytocin pathway genes have been associated with social behavior and psychiatric disorders (5). Emerging evidence also points to the oxytocin system's role in energy metabolism (6), with relevance for metabolic functions (7).
While central oxytocin receptor (OXTR) mRNA localization in the rodent brain is well-described (8), its anatomical distribution across the human brain is poorly understood, as investigations have tended to sample very few brain regions (9, 10). Partly attributed to this limited understanding of human central OXTR gene expression (11), the translational promise of oxytocin provided by preliminary clinical trials (e.g., 12, 13) has yet to be fulfilled. The distribution of OXTR mRNA across the brain provides a proxy for the distribution of central oxytocin binding (14, 15) , allowing for a detailed mapping of the anatomical geography of the oxytocin system in the human brain. Seminal animal work using histochemistry and immunohistochemistry revealed high concentrations of OXTR mRNA in the hypothalamus, amygdala, olfactory bulb, ventral pallidum, and the dorsal vagal nucleus (16, 17) . Further, experimentally increasing (18) or decreasing (19) OXTR expression in the prairie vole nucleus accumbens modulated partner preference behavior, suggesting an intriguing correspondence between the spatial distribution of OXTR mRNA, its functional neuroanatomy, and behavioral relevance.
In addition to the anatomical distribution of OXTR mRNA, characterizing its interactions with other key elements of the oxytocin signaling pathway and biological systems beyond this pathway is critical for determining oxytocin's behavioral and functional relevance. Along with OXTR, CD38 and oxytocin-neurophysin I (OXT) genes in the oxytocin signaling pathway have been implicated in human social behavior (5). Specifically, CD38 is involved in central oxytocin secretion (20) , and OXT encodes the oxytocin prepropeptide containing the nonapeptide oxytocin and the carrier protein neurophysin-I (21). OXT mRNA is highly expressed in human paraventricular nucleus of the hypothalamus, the lateral hypothalamic area, and the supraoptic nucleus, and there is evidence of co-expression with OXTR mRNA and the μ and κ types opioid receptor mRNA (22), providing a putative avenue for interactions between the oxytocin and opioid pathways .
The interactions with the oxytocin system extend beyond the opioid pathway, including the dopaminergic (23, 24) and muscarinic acetylcholine (9, 25) circuits, with possible implications for social behavior and psychiatric disorders. For instance, the dopamine D2-receptor subtype (DRD2), has been implicated in various putative intermediate phenotypes in psychiatric illness, including motivational processing (26) and pair bonding in animal models (27, 28) . Moreover, the muscarinic acetylcholine M4 receptor (CHRM4) has been associated with schizophrenia (29) and implicated in cognitive flexibility (30), social impairment (31), and dopamine release (32) . Finally, oxytocin can also bind to AVPR1A receptors (33) , which has also been linked to social functioning (34) . However, the mRNA co-expression of these systems, and potentially others, with the oxytocin system is not well characterized.
While brain regions with high oxytocin pathway gene expression in humans have been identified (9, 10, 22), inference of specific mental states from single brain regions is elusive. For instance, commonly observed increases in medial and lateral frontal region activity during emotion and pain processing seem to be better explained by more general sustained attention processes (35). Leveraging data from more than 11,000 fMRI studies, NeuroSynth (35) allows for reverse inference of mental states based on a given brain gene expression map with high specificity. Establishing the specific mental state correlates of oxytocin pathway genes will provide a deeper understanding of the central human oxytocin system and its relevance for brain functions and mental health.
By leveraging the Allen Human Brain Atlas, which offers a uniquely comprehensive gene expression survey from six neurotypical adult human brains, we first characterize the anatomical distribution of mRNA expression of OXT, OXTR and CD38, which are key constituents in the oxytocin pathway.
Second, we explore putative gene interactions by identifying mRNA maps with overlapping anatomical distributions with our target genes across all protein coding genes in the database, additionally focusing on selected dopamine, muscarinic acetylcholine, and vasopressin gene sets. Third, we decode the mental state relevance of the selected oxytocin genes using quantitative CRHM5) (9, 25), and a vasopressin set (AVPR1A, AVPR1B) (34, 37) . Of additional interest were complete sets of dopaminergic (n = 63), cholinergic (n = 79), and oxytocinergic (n = 94) genes, which were identified using the Kyoto
Encyclopaedia
of Genes and Genomes (KEGG) database (http://www.kegg.jp) (see Dataset S1 for a full list). If more than one probe for each mRNA was available, we selected the probe with the highest signal-tonoise ratio (mean/standard deviation), which represented the probe with least amount of spatial variability among donors (Dataset S2).
mRNA expression maps. While the Allen Human Brain Atlas is a comprehensive dataset, expression data is missing from some regions or not available from all donor samples. To assess accurate cognitive correlates of gene expression using meta-analysis via the NeuroSynth tool, voxel-by-voxel mRNA maps provide optimal information. To create these voxel-by-voxel volumetric expression maps, we first marked all the sample locations and expression values in native image space. To interpolate missing voxels, we labeled brain borders with the sample expression value that had the closest distance to a given border point ( Fig. S1a ). Next, we linearly interpolated the space between scattered points by dividing that space into simplices based on Delaunay triangulation ( Fig. S1b ), then linearly interpolated each simplex with values to yield a completed map ( Fig. S1c ). All maps were computed in Matlab 2014a (The Mathworks Inc., Natick, MA, USA). Next, we registered all the individual brains to the MNI152 (Montreal Neurological Institute) template using ANTs (Advanced Normalization Tools; 38). To extract region specific statistics for 54 brain regions, we used regions extracted based on the Automated Anatomical Label (AAL) atlas.
For out-of-sample validation, central oxytocin pathway median expression profiles for 10 distinct brain regions were extracted from the Genotype-Tissue Expression (GTEx) project database (39). Although this dataset offers less spatial precision, the data is derived from a larger dataset of donors (mean sample size for mRNA expression across brain regions = 131.7, range = 88 to 173). For this comparison, median gene expression for these 10 distinct GTEx regions were calculated using Allen dataset ( Fig. S2 ).
Spearman's rank correlation coefficients (r s ) were calculated to assess the relationship between oxytocin pathway expression profiles from the two databases. Sex differences in central oxytocin pathway gene expression were also examined in the GTEx sample.
Central gene expression.
Statistical analyses were performed with R statistical package (version 3.3.2). Across the brain, gene expression for the right hemisphere samples was highly correlated with the corresponding left hemisphere samples for gene expression values for oxytocin pathway genes (OXTR: r s = 0.89, p < 0.001 CD38: r s = 0.87, p < 0.001; OXT: r s = 0.78, p < 0.001). Thus, the left hemisphere was used for analysis given its higher sample size. One-sample t-tests (two-tailed) were conducted to assess which of the 54 left hemisphere regions from six donor samples expressed mRNA to a significantly greater or lesser degree compared to average mRNA expression across the brain. To correct for multiple tests (54 in total), reported p-values were adjusted using a false discovery rate (FDR) threshold. Cohen's d values for one-sample t-tests were calculated to yield a measure of effect size.
Based on raw expression data, we generated a 17 × 17 correlation matrix for each donor including the following selected genes (Oxytocin pathway set: OXTR, CD38, OXT; Dopaminergic set: DRD1, DRD2, DRD3, DRD4, DRD5, COMT, DAT1; muscarinic acetylcholine set: CRHM1, CRHM2, CRHM3, CRHM4, CRHM5; vasopressin set: AVPR1A, AVPR1B) and then averaged these matrices over the six donors. This mean correlation matrix was clustered using the complete linkage method (40) to assess coexpression patterns. To assess putative gene-gene interactions beyond selected gene sets, we computed the spatial Spearman's correlations between all available protein coding mRNA probes (n = 20737) and three oxytocin pathway mRNA probes. Finally, to explore whether these coexpression patterns are not driven by global expression differences between cortical and non-cortical areas, we visualized the similarities in expression patterns based on cortical areas only.
Mental state term correlates. To identify the mental state correlates of mRNA brain expression maps, we performed quantitative reverse inference via large-scale meta-analysis of functional neuroimaging data using the NeuroSynth framework (35). We created a composite brain map representing an average of 6 individuals on the left hemisphere. Using the NeuroSynth framework, we correlated our mRNA maps with specificity Z maps, reflecting the posterior probability maps, which display the likelihood of a given mental state term being used in a study if activation is observed at a particular voxel.
This analysis was based on text-mining a corpus of 11,406 fMRI studies. We assessed the 15 strongest relationships (Spearman's r) between OXTR, CD38, and OXT expression maps (5 unique terms for each gene) and all available mental state (i.e., non-anatomical) maps available in the NeuroSynth database. To test for specificity, we also assessed the relationship between these 15 mental state maps and the 20737 mRNA maps. We plotted these distributions and identified the rank of OXTR, CD38, and OXT Spearman's r value compared to all other associations.
Data and analysis script availability. mRNA expression data is available
from Allen Human Brain Atlas (http://human.brain-map.org) and GTEx (http://gtexportal.org). The Matlab script for producing the brain region-specific data, the resulting dataset, and the R script used for statistical analysis is available at https://osf.io/jp6zs/.
Results

Central gene expression.
Compared to average expression across the brain, high expression of OXTR mRNA levels was observed in the olfactory bulbs (p = .001, d = 7.3), caudate (p = .001, d = 5.3), putamen (p = .003, d = 3.6), pallidum (p = .007, d = 2.9), amygdala (p = .01, d = 2.4), parahippocampal region (p = .03, d = 1.9), and hippocampus (p =.03, d = 1.8).
There was lower OXTR expression in the cerebral crus I (p = .02, d = 2.1), cerebral crus II (p = .003, d = 3.7), cerebellum 7b (p = .003, d = 3.6), and cerebellum 8 (p = .002, d = 4.6; Fig. 1a ; Dataset S3). Central OXTR expression patterns were comparable to patterns in the GTEx database (r s = 0.77, p = 0.01; Fig. S3 ). CD38 gene expression was higher than average in the caudate (p = .003, d = 4.4), pallidum (p = .003, d = 4.4) olfactory bulbs (p = .01, d = 3.1), putamen (p = .02, d = 2.8), thalamus (p = .04, d = 2.1), and cingulate anterior (p = .047, d = 1.8; Fig. 1b ). There was lower CD38 expression in the middle temporal pole (p = .047, d = 1.9) and cerebellum 7b A Spearman's correlation matrix demonstrating the relationships between the genes of interest using the raw expression data is presented in Figure 2a . Hierarchical clustering revealed that that the oxytocin pathway genes (OXTR, CD38, OXT) cluster with elements of the dopaminergic system (DRD1, DAT1, COMT, DRD2), CHRM4 and CHRM5. The correlation of each of these genes within its complete gene set family is visualized in Figure 2b . A comparison of expression patterns across the all brain regions and only cortical samples suggest that OXTR and CD38 relationships appear to be global, whereas OXT co-expression seems to be driven by correlations within cortical areas ( Fig. S9 ). Histograms of the correlations between the three oxytocin pathway mRNA probes and all other available mRNA probes are presented in Figure 3 . Exploratory correlation analyses with all available 20737 protein coding gene probes in the Allen Human Brain Atlas and each of the three oxytocin pathway gene probes are summarized in Table S2, and OXT mRNA expression maps were most highly correlated with functional imaging maps with motivation-related topics (e.g., "reward", "anticipation", "incentive"), emotion-processing, and aversive-related topics ( Fig. 5a , Table   S3 ). Figure 5b shows the full distribution of correlation coefficients for each mental state term across all 20737 gene maps, with labelled oxytocin pathway genes and their absolute rank for each term (Table S3 ). Notably, the OXTR map was ranked among the top 100 out of 20737 genes for several functional imaging maps (i.e., the top 0.5%).
Discussion
The anatomical distribution of gene expression in the brain is heterogeneous and highly coordinated (41). Whereas dynamic alterations in gene expression are essential in response to environmental demands, and are critically involved in a range of cognitive functions, learning, and diseases (42, 43), the basic organization likely partly reflects the evolutionary conserved modular layout of the brain (44). Indeed, gene-gene co-expression patterns form specific genetic signatures in the brain, representing distinct tissues and biological systems (41), and likely reflect the potential of complex and differential gene-gene interactions with implications for brain disorders and mental health. Here, we leveraged the unique human brain mRNA expression library from Allen Brain Atlas to show that mRNA reflecting specific genes in the oxytocin pathway are highly expressed in central and temporal brain structures, along with the olfactory region. We also show reduced expression of OXTR and CD38 in the cerebellum, consistent with prior animal research (45). Importantly, the observed oxytocin pathway expression patterns from the Allen database, particularly OXTR and CD38, were consistent with oxytocin pathway expression patterns observed in the GTEx database.
Oxytocin pathway genes showed considerable co-expression with DRD2, COMT, DAT1, and CHRM4 genes, providing evidence for putative interactions between dopaminergic and muscarinic acetylcholine systems with the central oxytocin pathways. Exploratory analysis between oxytocin pathway mRNA and 20737 mRNA probes revealed several relationships worth noting in the context of metabolic and feeding regulation, as well as psychiatric disorders. We discovered that OXTR is highly co-expressed with Neurotensin receptor gene (NTSR2), which has been found to regulate ethanol consumption in mice (46), and Glutamate dehydrogenase 1 and 2 (GLUD1, GLUD2), which are involved in energy homeostasis and insulin secretion (47-49). Second, CD38 is highly co-expressed with NTSR2, GLUD1, and SPX (Spexin), with the latter associated with weight regulation (50).
These results are consistent with emerging evidence that the oxytocin system may play a role in the metabolic and feeding dysregulation often observed in severe mental illnesses (7). In regards to psychiatric disorders, there were also strong negative correlations between oxytocin pathway genes and CADPS2, which has been associated with autism (51) and autistic-like phenotypes in mice (52), PAK7 and RTN4R (Nogo-66), which have been associated with schizophrenia (53, 54), and GALNT17 (WBSCR17), which has been associated with William's syndrome (55). Quantitative reverse inference via meta-analysis of 11,406 fMRI studies also revealed that the distribution of the central genetic oxytocin pathway is most strongly associated with terms related to motivation and emotion, supporting the genesystem interactions suggested by the gene co-expression patterns.
Compelling rodent evidence suggests that direct central oxytocin administration influences social behavior and cognition via action on central oxytocin receptors (56). In these animals, oxytocin receptors are located in regions that are crucial for social behavior and the processing of social cues (8). Our data reveals striking similarities with central oxytocin pathway mRNA distribution observed in rodents (16, 17) and non-human primates (57).
Additionally, our data provides evidence that oxytocin may exert its effects synergistically with the dopaminergic network (23). Indeed, the oxytocin and dopaminergic systems work in concert to promote rodent maternal behaviors (58) and central D2 receptors modulate social functioning in prairie voles (59, 60). There is also evidence of direct dopaminergic fibers to the supraoptic nucleus and the paraventricular nucleus (61), consistent with demonstrations that dopamine may stimulate oxytocin release in the hypothalamus (62). This is also congruous with reported deficits in dopaminergic signaling in schizophrenia (63) and autism (64). The muscarinic acetylcholine system may also work with the oxytocin system to boost attention (65) and to assist with the release of oxytocin (66). Relatedly, the muscarinic acetylcholine system is thought to contribute to the cognitive dysfunction observed in schizophrenia (67). Altogether, these findings are consistent with a role of oxytocin in the processing of social stimuli and corroborate emerging evidence for interactions between the oxytocin, acetylcholine (9), and dopaminergic systems (23), and for oxytocin's role in metabolic regulation (7).
Our data revealed high expression of oxytocin pathway mRNA in the olfactory region, which is in line with animal research (e.g., 68). Indeed, social olfactory deficits in mice without the oxytocin gene (69) are rescued with injection of oxytocin into rat olfactory bulbs (70). Increased mRNA in the human olfactory region may be vestigial, as olfaction is not as important for human conspecific identification compared to most other mammals due to species specialization, however, intranasal oxytocin has been shown to improve olfactory detection performance in schizophrenia (71), and intranasal oxytocin is thought to enter the brain via the olfactory bulbs (72).
There are some important limitations worth noting. First, given the It has been suggested that comprehensive clinical trials need to demonstrate engagement of drug targets, such as OXTR occupancy reflected by regional brain activity changes (11). Without precise targets, it is unclear whether non-significant effects of intranasal oxytocin, beyond insufficient statistical power (74), are due to an inefficacious drug or misidentified drug targets. By identifying accurate oxytocin pathway targets in the human brain, our study provides a tentative oxytocin treatment target map that may help facilitate efforts to better understand oxytocin treatment efficacy (11, 72).
Analysis of data from the Allen Brain Atlas database provides a unique opportunity to map the central oxytocin system and explore co-expression with other systems. Altogether, these results provide a proof-of-principle demonstration of corresponding cognitive and gene expression patterns of a neuropeptide pathway involved in complex human behaviors. Distribution of vasopressin and oxytocin in rat brain. Endocrinol. Jpn.
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